ADVANCED GASTRIC CANCER
Clinical trials for ADVANCED GASTRIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough stomach cancers
Disease control CompletedThis study tested a new drug called gentuximab combined with the chemotherapy drug paclitaxel in 76 people with advanced stomach or gastroesophageal junction cancer that had worsened after initial treatment. The goal was to find a safe and effective dose and see if the combinatio…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control CompletedThis study tested whether adding fruquintinib to standard chemotherapy (paclitaxel) helps people with advanced stomach cancer live longer. It included 703 patients whose cancer had worsened after initial treatment. The goal was to see if the combination improves survival and slow…
Matched conditions: ADVANCED GASTRIC CANCER
Phase: PHASE3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Real-World check: does adding nivolumab to chemo help stomach cancer patients?
Knowledge-focused CompletedThis study looked at how well a combination of nivolumab (an immunotherapy drug) and chemotherapy works for people with advanced or recurrent stomach cancer who haven't had treatment before. It involved 500 patients in Japan and tracked things like how long the cancer stayed unde…
Matched conditions: ADVANCED GASTRIC CANCER
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC